Role and development of GLP-1 receptor agonists in the management of diabetes
Chee W Chia, Josephine M EganNational Institutes of Health, National Institute on Aging, Intramural Research Program, Baltimore, Maryland, USAAbstract: Glucagon-like peptide-1 (GLP-1) is a hormone secreted from enteroendocrine L cells of the intestine in response to food. Exogenous GLP-...
Saved in:
Main Authors: | Chee W Chia, Josephine M Egan |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/557b3719c76d42cf8151d5df75f42c68 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging role of GLP-1 receptor agonists in the treatment of obesity
by: Lisa M Neff, et al.
Published: (2010) -
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
by: Stolar MW, et al.
Published: (2013) -
Emerging role of GLP-1 receptor agonists in the treatment of obesity
by: Neff LM
Published: (2010) -
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
by: Lindsay Zilliox, et al.
Published: (2010) -
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
by: Cyrus V Desouza, et al.
Published: (2009)